Name of study:
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Purpose of study:
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
Is the study of a controlled or observational design?
Where is the study being conducted?
Massive Bio, Inc
City and State:
When the study is being conducted:
Start Date: 1/1/2018
End date: 12/1/2022
What website should a person use to register for the study?
Who should a person contact to register for the study?
Name: Massive Bio
Email: [email protected]
Who is sponsoring this study?
Massive Bio, Inc.
What is the identifier for this study on ClinicalTrials.gov?
Page last updated: December 3, 2020